Foresite Capital Management Iv, LLC Xenon Pharmaceuticals Inc. Transaction History
Foresite Capital Management Iv, LLC
- $156 Million
- Q3 2025
A detailed history of Foresite Capital Management Iv, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 160,000 shares of XENE stock, worth $6.52 Million. This represents 4.12% of its overall portfolio holdings.
Number of Shares
160,000
Previous 160,000
-0.0%
Holding current value
$6.52 Million
Previous $5.01 Million
28.27%
% of portfolio
4.12%
Previous 5.51%
Shares
3 transactions
Others Institutions Holding XENE
# of Institutions
238Shares Held
73.9MCall Options Held
235KPut Options Held
271K-
Avoro Capital Advisors LLC New York, NY5.4MShares$220 Million2.96% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.17MShares$170 Million1.42% of portfolio
-
Janus Henderson Group PLC London, X03.94MShares$161 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.61MShares$147 Million0.03% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$147 Million8.35% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.54B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...